Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages 1134-1145

  Fiore, Emilio ^a   Vitti, Paolo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROTROPIN;

ANXIETY; AUTOIMMUNITY; CANCER RISK; CANCER STAGING; DISEASE ASSOCIATION; DRUG EFFICACY; ENZYME ACTIVITY; HEAT INTOLERANCE; HORMONAL THERAPY; HUMAN; NERVOUSNESS; NODULAR GOITER; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SIDE EFFECT; SYSTEMATIC REVIEW; THYROID CANCER; THYROTROPIN BLOOD LEVEL; TREMOR;

ANIMALS; CARCINOMA, PAPILLARY; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; RISK; THYROID NEOPLASMS; THYROID NODULE; THYROIDITIS, AUTOIMMUNE; THYROTROPIN; THYROXINE;

EID: 84859530210     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2735     Document Type: Review

References (108)

1. Hegedü s L 2004 Clinical practice. The thyroid nodule. N Engl J Med 351:1764-1771
2. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA 1977 The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481-493 (Pubitemid 8235965)
3. Vander JB, Gaston EA, Dawber TR 1968 The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69:537-540
4. Hegedü s L 2001 Thyroid ultrasound. Endocrinol Metab Clin North Am 30:339-360, viii-ix
5. Knudsen N, Laurberg P, Perrild H, Bü low I, Ovesen L, Jørgensen T 2002 Risk factors for goiter and thyroid nodules. Thyroid 12:879-888 (Pubitemid 35332992)
6. Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES, Mandel SJ 2000 Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 133:696-700
7. Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, Schumm-Draeger PM 2004 Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 14:926-932 (Pubitemid 39612911)
8. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167
9. Yu GP, Li JC, Branovan D, McCormick S, Schantz SP 2010 Thyroid cancer incidence and survival in the National Cancer Institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid 20:465-473
10. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803 (Pubitemid 43997716)
11. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R 1992 Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93:363-369
12. Hegedü s L, Bonnema SJ, Bennedbaek FN 2003 Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102-132
13. Morganti S, Ceda GP, Saccani M, Milli B, Ugolotti D, Prampolini R, Maggio M, Valenti G, Ceresini G 2005 Thyroid disease in the elderly: sex-related differences in clinical expression. J Endocrinol Invest 28:101-104
14. Polyzos SA, Kita M, Avramidis A 2007 Thyroid nodules - stepwise diagnosis and management. Hormones (Athens) 6:101-119
15. Tuttle RM, Lemar H, Burch HB 1998 Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 8:377-383 (Pubitemid 28252418)
16. Rago T, Fiore E, Scutari M, Santini F, Di Coscio G, Romani R, Piaggi P, Ugolini C, Basolo F, Miccoli P, Pinchera A, Vitti P 2010 Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease. Eur J Endocrinol 162:763-770
17. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA 2006 Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295-4301 (Pubitemid 44833401)
18. Fiore E, Rago T, Provenzale MA, Scutari M, Ugolini C, Basolo F, Di Coscio G, Berti P, Grasso L, Elisei R, Pinchera A, Vitti P 2009 Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 16:1251-1260
19. Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore Jr FD, Larsen PR, Marqusee E, Alexander EK 2006 Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 91:3411-3417 (Pubitemid 44402112)
20. Nosé V2010 Familial follicular cell tumors: classification and morphological characteristics. Endocr Pathol 21:219-226
21. Castro MR, Gharib H 2003 Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls. Endocr Pract 9:128-136
22. Gharib H 1997 Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 26:777-800 (Pubitemid 27528198)
23. Burch HB 1995 Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin North Am 24:663-710
24. Cersosimo E, Gharib H, Suman VJ, Goellner JR 1993 "Suspicious" thyroid cytologic findings: outcome in patients without immediate surgical treatment. Mayo Clin Proc 68:343-348 (Pubitemid 23097663)
25. Chow LS, Gharib H, Goellner JR, van Heerden JA 2001 Nondiagnostic thyroid fine-needle aspiration cytology: management dilemmas. Thyroid 11:1147-1151 (Pubitemid 34041895)
26. Tan GH, Gharib H, Reading CC 1995 Solitary thyroid nodule. Comparison between palpation and ultrasonography. Arch Intern Med 155:2418-2423
27. Jonklaas J, Nsouli-Maktabi H, Soldin SJ 2008 Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid 18:943-952
28. Polyzos SA, Kita M, Efstathiadou Z, Poulakos P, Slavakis A, Sofianou D, Flaris N, Leontsini M, Kourtis A, Avramidis A 2008 Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Oncol 134:953-960
29. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H 2008 Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 93:809-814 (Pubitemid 351398557)
30. Haymart MR, Glinberg SL, Liu J, Sippel RS, Jaume JC, Chen H 2009 Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol (Oxf) 71:434-439
31. Jin J, Machekano R, McHenry CR 2010 The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease. Am J Surg 199:294-297; discussion 298
32. Gerschpacher M, Göbl C, Anderwald C, Gessl A, Krebs M 2010 Thyrotropin serum concentrations in patients with papillary thyroid microcancers. Thyroid 20:389-392
33. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP 2001 Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 22:631-656 (Pubitemid 32955247)
34. Tonacchera M, Van Sande J, Parma J, Duprez L, Cetani F, Costagliola S, Dumont JE, Vassart G 1996 TSH receptor and disease. Clin Endocrinol (Oxf) 44:621-633 (Pubitemid 26225177)
35. Ledent C, Parmentier M, Maenhaut C, Taton M, Pirson I, Lamy F, Roger P, Dumont JE 1991 The TSH cyclic AMP cascade in the control of thyroid cell proliferation: the story of a concept. Thyroidology 3:97-101
36. Schaller Jr RT, Stevenson JK 1966 Development of carcinoma of the thyroid in iodine-deficient mice. Cancer 19:1063-1080
37. Fortner JG, George PA, Sternberg SS 1960 Induced and spontaneous thyroid cancer in the Syrian (golden) hamster. Endocrinology 6:364-376
38. Farid NR, Shi Y, Zou M 1994 Molecular basis of thyroid cancer. Endocr Rev 15:202-232 (Pubitemid 24129183)
39. Wynford-Thomas D 1993 Molecular genetics of thyroid cancer. Trends Endocrinol Metab 4:224-232 (Pubitemid 23293310)
40. Feldt-Rasmussen U 2001 Iodine and cancer. Thyroid 11:483-486 (Pubitemid 32496288)
41. Biondi B, Filetti S, Schlumberger M 2005 Thyroid-hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab 1:32-40
42. Mazzaferri EL 1999 An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9:421-427 (Pubitemid 29244917)
43. Sipos JA, Mazzaferri EL 2008 The therapeutic management of differentiated thyroid cancer. Expert Opin Pharmacother 9:2627-2637
44. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306 (Pubitemid 28065257)
45. Ciampi R, Nikiforov YE 2007 RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis. Endocrinology 148:936-941
46. Nikiforova MN, Nikiforov YE 2008 Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn 8:83-95
47. Franco AT, Malaguarnera R, Refetoff S, Liao XH, Lundsmith E, Kimura S, Pritchard C, Marais R, Davies TF, Weinstein LS, Chen M, Rosen N, Ghossein R, Knauf JA, Fagin JA 2011 Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice. Proc Natl Acad Sci USA 108:1615-1620
48. Kumar H, Daykin J, Holder R, Watkinson JC, Sheppard MC, Franklyn JA 1999 Gender, clinical findings, and serum thyrotropin measurements in the prediction of thyroid neoplasia in 1005 patients presenting with thyroid enlargement and investigated by fine-needle aspiration cytology. Thyroid 9:1105-1109
49. Fiore E, Rago T, Latrofa F, Provenzale MA, Piaggi P, Delitala A, Scutari M, Basolo F, Di Coscio G, Grasso L, Pinchera A, Vitti P 2011 Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer 18:429-437
50. Zafon C, Obiols G, Baena JA, Castellví J, Dalama B, Mesa J 2012 Preoperative thyrotropin serum concentrations gradually increase from benign thyroid nodules to papillary thyroid microcarcinomas, then to papillary thyroid cancers of larger size. J Thyroid Res 2012:530721
51. Gul K, Ozdemir D, Dirikoc A, Oguz A, Tuzun D, Baser H, Ersoy R, Cakir B 2010 Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin? Endocrine 37:253-260
52. Hands KE, Cervera A, Fowler LJ 2010 Enlarged benign-appearing cervical lymph nodes by ultrasonography are associated with increased likelihood of cancer somewhere within the thyroid in patients undergoing thyroid nodule evaluation. Thyroid 20:857-862
53. Kim KW, Park YJ, Kim EH, Park SY, Park do J, Ahn SH, Park do J, Jang HC, Cho BY 2011 Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis. Head Neck 33:691-695
54. Castro MR, Espiritu RP, Bahn RS, Henry MR, Gharib H, Caraballo PJ, Morris JC 2011 Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid 21:1191-1198
55. Derwahl M, Studer H 2001 Nodular goiter and goiter nodules: where iodine deficiency falls short of explaining the facts. Exp Clin Endocrinol Diabetes 109:250-260 (Pubitemid 32738109)
56. Studer H, Peter HJ, Gerber H 1989 Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth. Endocr Rev 10:125-135 (Pubitemid 19151340)
57. Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, Rago T, Grasso L, Valeriano R, Balestrieri A, Pinchera A 1999 The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 84:561-566 (Pubitemid 29075684)
58. Fenzi GF, Ceccarelli C, Macchia E, Monzani F, Bartalena L, Giani C, Ceccarelli P, Lippi F, Baschieri L, Pinchera A 1985 Reciprocal changes of serum thyroglobulin and TSH in residents of a moderate endemic goitre area. Clin Endocrinol (Oxf) 23:115-122 (Pubitemid 15015332)
59. Vitti P, Mariotti S, Marcocci C, Chiovato L, Giachetti M, Fenzi G, Pinchera A 1990 Thyroid autoimmunity and thyroid autonomy. Acta Med Austriaca 17(Suppl 1):90-92
60. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499 (Pubitemid 34158210)
61. Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR 2007 Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid 17:1211-1223
62. Surks MI, Hollowell JG 2007 Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 92:4575-4582 (Pubitemid 350223429)
63. Ngan ES, Lang BH, Liu T, Shum CK, So MT, Lau DK, Leon TY, Cherny SS, Tsai SY, Lo CY, Khoo US, Tam PK, Garcia-BarcelóMM 2009 A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma. J Natl Cancer Inst 101:162-175
64. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Commonvariants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464
65. Kim SS, Lee BJ, Lee JC, Song SH, Kim BH, Son SM, Kim IJ, Kim YK, Kang YH 2011 Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience. Endocrine 39:259-265
66. Dailey ME, Lindsay S, Skahen R 1955 Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 70:291-297
67. Hirabayashi RN, Lindsay S 1965 The relation of thyroid carcinoma and chronic thyroiditis. Surg Gynecol Obstet 121:243-252
68. Ott RA, McCall AR, McHenry C, Jarosz H, Armin A, Lawrence AM, Paloyan E 1987 The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am Surg 53:442-445 (Pubitemid 17122376)
69. Ott RA, Calandra DB, McCall A, Shah KH, Lawrence AM, Paloyan E 1985 The incidence of thyroid carcinoma in patients with Hashimoto's thyroiditis and solitary cold nodules. Surgery 98:1202-1206 (Pubitemid 16104745)
70. Okayasu I 1997 The relationship of lymphocytic thyroiditis to the development of thyroid carcinoma. Endocr Pathol 8:225-230 (Pubitemid 127499152)
71. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR 1995 Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 76:2312-2318
72. Mizukami Y, Michigishi T, Nonomura A, Hashimoto T, Noguchi M, Matsubara F, Watanabe K 1992 Carcinoma of the thyroid at a young age - a review of 23 patients. Histopathology 20:63-66
73. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF 1986 Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 61:978-996 (Pubitemid 17205209)
74. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP 1999 Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126:1070-1076; discussion 1076-1077
75. Baker Jr JR 1995 The immune response to papillary thyroid cancer. J Clin Endocrinol Metab 80:3419-3420
76. Crile Jr G, Hazard JB 1962 Incidence of cancer in struma lymphomatosa. Surg Gynecol Obstet 115:101-103
77. Holm LE, Blomgren H, Löwhagen T 1985 Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312:601-604 (Pubitemid 15133674)
78. Boi F, Lai ML, Marziani B, Minerba L, Faa G, Mariotti S 2005 High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur J Endocrinol 153:637-642 (Pubitemid 41672409)
79. Fiore E, Rago T, Scutari M, Ugolini C, Proietti A, Di Coscio G, Provenzale MA, Berti P, Grasso L, Mariotti S, Pinchera A, Vitti P 2009 Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases. J Endocrinol Invest 32:344-351
80. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55-68
81. Walsh JP, Bremner AP, Feddema P, Leedman PJ, Brown SJ, O'Leary P 2010 Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab 95:1095-1104
82. Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A 1990 Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 71:661-669 (Pubitemid 20286067)
83. Knobel M, Barca MF, Pedrinola F, Medeiros-Neto G 1994 Prevalence of anti-thyroid peroxidase antibodies in autoimmune and nonautoimmune thyroid disorders in a relatively low-iodine environment. J Endocrinol Invest 17:837-842
84. Marcocci C, Vitti P, Cetani F, Catalano F, Concetti R, Pinchera A 1991 Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab 72:209-213 (Pubitemid 21921677)
85. Rago T, Chiovato L, Grasso L, Pinchera A, Vitti P 2001 Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dysfunction in apparently healthy subjects. J Endocrinol Invest 24:763-769 (Pubitemid 33120970)
86. Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, Kwon HS, Song KH, Kang MI, Cha BY, Lee KW, Son HY 2010 Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 20:885-891
87. Latrofa F, Ricci D, Vitti P, Prinzis A, Cambuli VM, Ghiani M, Pilia S, Carta D, Loche S, Pinchera A, Mariotti S 2010 Characterization of thyroglobulin epitopes in Sardinian adults and juveniles with Hashimoto's thyroiditis: evidence against a major effect of age and genetic background on B-cell epitopes. Clin Endocrinol (Oxf) 73:110-113
88. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428 (Pubitemid 24345593)
89. Goldberg RC, Lindsay S, Nichols Jr CW, Chaikoff IL 1964 Induction of neoplasms in thyroid glands of rats by subtotal thyroidectomy and by the injection of one microcurie of I-131. Cancer Res 24:35-43
90. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P 2010 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract 16:468-475
91. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
92. Fiore E, Rago T, Provenzale MA, Scutari M, Ugolini C, Basolo F, Di Coscio G, Miccoli P, Grasso L, Pinchera A, Vitti P 2010 L-Thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27,914 patients. Endocr Relat Cancer 17:231-239
93. La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A 1995 Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122:1-8
94. Sdano MT, Falciglia M, Welge JA, Steward DL 2005 Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials. Otolaryngol Head Neck Surg 133:391-396 (Pubitemid 41247731)
95. Lima N, Knobel M, Cavaliere H, Sztejnsznajd C, Tomimori E, Medeiros-Neto G 1997 Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 7:691-697 (Pubitemid 28086199)
96. Berghout A, Wiersinga WM, Drexhage HA, Smits NJ, Touber JL 1990 Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet 336:193-197 (Pubitemid 20229056)
97. Wesche MF, Tiel-V Buul MM, Lips P, Smits NJ, Wiersinga WM 2001 A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 86:998-1005
98. Castro MR, Caraballo PJ, Morris JC 2002 Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 87:4154-4159
99. Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA 1987 Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 317:70-75 (Pubitemid 17093734)
100. Reverter JL, Lucas A, Salinas I, Audí L, Foz M, Sanmartí A 1992 Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36:25-28
101. Zelmanovitz F, Genro S, Gross JL 1998 Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 83:3881-3885 (Pubitemid 28513566)
102. Larijani B, Pajouhi M, Bastanhagh MH, Sadjadi A, Sedighi N, Eshraghian MR 1999 Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double-blind placebo-controlled clinical trial. Endocr Pract 5:251-256
103. Wémeau JL, Caron P, Schvartz C, Schlienger JL, Orgiazzi J, Cousty C, Vlaeminck-Guillem V 2002 Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 87:4928-4934 (Pubitemid 35316327)
104. Papini E, Bacci V, Panunzi C, Pacella CM, Fabbrini R, Bizzarri G, Petrucci L, Giammarco V, La Medica P, Masala M 1993 A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol (Oxf) 38:507-513 (Pubitemid 23153413)
105. Biondi B, Cooper DS 2008 The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29:76-131 (Pubitemid 351252748)
106. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostino RB 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249-1252 (Pubitemid 24333188)
107. Heijckmann AC, Huijberts MS, Geusens P, de Vries J, Menheere PP, Wolffenbuttel BH 2005 Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive Lthyroxine therapy for differentiated thyroid carcinoma. Eur J Endocrinol 153:23-29 (Pubitemid 41038390)
108. Williams JB 1997 Adverse effects of thyroid hormones. Drugs Aging 11:460-469 (Pubitemid 27524941)